A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
HCPs are busier than ever, and for marketers, this means they’re harder to reach and possibly even disconnected -- here's how to get through to this valuable audience.
Erin Deruggiero, Chief Digital Officer at Swoop, sat down with Marc Iskowitz, Editor in Chief of MM+M to discuss the increased benefits to both marketers and patients when campaigns align.
Background Spondyloarthritis (SpA), the group of conditions that includes ankylosing spondylitis, psoriatic arthritis, and non-radiographic axial spondyloarthritis, among others, can lead to symptoms of pain, stiffness, and swelling. The burden of disease can affect patients’ quality of life. Objectives Patient research was undertaken to explore the impact of spondyloarthritis on quality of life, patients’ ability […]
During an MM+M podcast, sponsored by Swoop, [email protected], SVP of sales, explained how custom audience segments can be activated across the media plan.